Enfermedad de Parkinson
The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson’s disease: a cross-sectional PET...
The Lancet Neurology Fecha de publicación: 15 February 2018 DOI: https://doi.org/10.1016/S1474-4422(18)30032-2 Autores: Shu-Ying Liu, Daryl J Wile, Jessie Fanglu Fu, Jason Valerio, Elham...
Lo más popular
The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages... 
Association between diabetes and subsequent Parkinson disease 
Effectiveness of Rotigotine plus intensive and goal-based rehabilitation versus Rotigotine... 
Wearable sensors for clinical applications in epilepsy, Parkinson’s disease, and stroke: a... 
Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systemati... 
Se vincula la exposición al manganeso con el Parkinson 
Parkinson’s disease determinants, prediction and gene–environment interactions in the UK B...